Lorbrena 25 mg

Lorbrena 25 mg tablets contain lorbatinib, a medication used to treat certain types of cancer. This oral tablet is manufactured by Pfizer Canada ULC and is available in a 25 mg strength.

Lorbrena 25 mg tablets are primarily used in the treatment of specific types of cancer. Lorbatinib, the active ingredient, is designed to target certain cancer cells. Patients often wonder, 'What is Lorbrena used for?' This medication is typically prescribed for advanced or metastatic cancers that have specific genetic markers.

Common effects of Lorbrena 25 mg tablets may include fatigue, nausea, and diarrhea. Some patients may experience changes in appetite or weight. It's important to note that individual responses to medication can vary, and not everyone will experience these effects.

Lorbrena 25 mg tablets should be handled with care. Store the medication in a cool, dry place away from direct sunlight. Always follow the advice of a healthcare professional regarding the use of this medication. Do not share this medication with others, even if they have similar symptoms.

Lorbrena 25 mg tablets may interact with certain medications, including those that are metabolized by the liver. It's important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol consumption should be discussed with a healthcare professional, as it may affect the efficacy of the medication.